viral-infection

Documents about viral-infection

• biomArkers to differeNtiate bacTerial From vIral iNfEctions#992887ClinicalTrials.gov
• Crosstalk between vimentin and keratins in viral infection: Implications across the viral life cycle#4522Europe PMC
• Respiratory Viral Infections in Pediatric Transplantation#1008499ClinicalTrials.gov
• Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)#417567ClinicalTrials.gov
• Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)#905123ClinicalTrials.gov
• Phase separation in viral infections#142644HAL (France)
• Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients#834233ClinicalTrials.gov
• Agent-based modelling of viral infection.#641816DORAS
• Exploration of HIV Reservoirs#837563ClinicalTrials.gov
• Follow-up of the Nasal Microbiome and Viral Infections in Newborns Hospitalised in Neonatology.#1010479ClinicalTrials.gov
• Viral Specific T-cells for Treatment of COVID-19#993065ClinicalTrials.gov
• Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant#859804ClinicalTrials.gov
• Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections#916464ClinicalTrials.gov
• Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis#429768ClinicalTrials.gov
• Azithromycin Plus Hydroxychloroquine for COVID-19 Infection#912113ClinicalTrials.gov
• Establish MeMed BV™ Performance for Differentiating Bacterial From Viral Infection in Suspected Acute Infection Patients (APOLLO STUDY)#879745ClinicalTrials.gov
• Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections#253079ClinicalTrials.gov
• Oral Ivermectin for Chikungunya Viral Infection#121440ClinicalTrials.gov
• Assess a Diagnostic Tool to Distinguish Between Bacterial and Viral Infection#141050ClinicalTrials.gov
• Anakinra in the Management of COVID-19 Infection#993491ClinicalTrials.gov
• Seawater Nasal Wash to Relieve COVID-19 Nasal Symptoms and Reduce SARS-CoV-2 Viral Load.#994602ClinicalTrials.gov
• Wells and Enteric Disease Transmission Trial (WET - Trial)#831957ClinicalTrials.gov
• Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection#852354ClinicalTrials.gov
• Role of lipofibroblasts in alveolar regeneration after viral infection#354293JLUpub
• Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections#887616ClinicalTrials.gov
• Impact of Respiratory Viral Infections in Infants With Cystic Fibrosis.#909538ClinicalTrials.gov
• Randomized Controlled Trial of Vitamin D3 Supplementation for Viral Upper Respiratory Tract Infections (URI) Prevention#891363ClinicalTrials.gov
• Characterising the Effects of Viral Infection on Human DEAD-box Protein 3 and its Interactions with Host and Viral RNA#354391MURAL
• A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised#904272ClinicalTrials.gov
• Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load#121430ClinicalTrials.gov
• Viral commitment to infection depends on host metabolism.#472551NCBI PubMed Central
• Airway macrophage specific glycocalyx expression and remodeling following viral infection#477163PubMed Central
• Can COVID-19 Persist in Intraocular Fluid?#840671ClinicalTrials.gov
• Xylitol Based Nasal Spray for COVID-19 Treatment#909376ClinicalTrials.gov
• Wells and Enteric Disease Transmission#850182ClinicalTrials.gov
• Viral Infections of the Central Nervous System: Diagnosis and Clinical Outcome#901794ClinicalTrials.gov
• Triggering of viral and bacterial respiratory infection hospitalizations by traffic pollution exposure in a cohort of hospitalized adults#365141PLOS
• Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic Fibrosis#845653ClinicalTrials.gov
• Convalescent Antibodies Infusion in COVID 19 Patients#992619ClinicalTrials.gov
• Combination of Leukocyte Cell Surface Biomarkers Measured by Cytometry, to Differentiate Bacterial From Viral Infections in Emergency Department: a Multicentric Cohort for the Validation of Diagnostic Performances#891306ClinicalTrials.gov
• TETRAVI Expanded Access Program#883615ClinicalTrials.gov
• Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2#813186ClinicalTrials.gov
• UNDERSTANDING IMMUNE DYNAMICS IN SARS-COV-2 RE-INFECTION AND VIRAL REACTIVATION#15721DataCite
• UNDERSTANDING IMMUNE DYNAMICS IN SARS-COV-2 RE-INFECTION AND VIRAL REACTIVATION#15722DataCite
• Herpes zoster ophthalmicus with prolonged viral shedding following COVID-19 infection#466999ARPHA OAI-PMH Endpoint
• Exercise and COVID-19 Viral T-cell Immunity#253049ClinicalTrials.gov
• Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry#853915ClinicalTrials.gov
• Reducing Urban Cervical Cancer Disparities#966232ClinicalTrials.gov
• Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)#903028ClinicalTrials.gov
• UNDERSTANDING PLACENTAL IMMUNITY: CYTOKINE CONTROL OF CONGENITAL VIRAL INFECTION#263698ScholarlyCommons at Penn